436 related articles for article (PubMed ID: 29658779)
21. Performance of Omnipod Personalized Model Predictive Control Algorithm with Moderate Intensity Exercise in Adults with Type 1 Diabetes.
Forlenza GP; Buckingham BA; Christiansen MP; Wadwa RP; Peyser TA; Lee JB; O'Connor J; Dassau E; Huyett LM; Layne JE; Ly TT
Diabetes Technol Ther; 2019 May; 21(5):265-272. PubMed ID: 30925077
[No Abstract] [Full Text] [Related]
22. Clinical evaluation of an automated artificial pancreas using zone-model predictive control and health monitoring system.
Harvey RA; Dassau E; Bevier WC; Seborg DE; Jovanovič L; Doyle FJ; Zisser HC
Diabetes Technol Ther; 2014 Jun; 16(6):348-57. PubMed ID: 24471561
[TBL] [Abstract][Full Text] [Related]
23. The International Diabetes Closed-Loop Study: Testing Artificial Pancreas Component Interoperability.
Anderson SM; Dassau E; Raghinaru D; Lum J; Brown SA; Pinsker JE; Church MM; Levy C; Lam D; Kudva YC; Buckingham B; Forlenza GP; Wadwa RP; Laffel L; Doyle FJ; DeVries JH; Renard E; Cobelli C; Boscari F; Del Favero S; Kovatchev BP
Diabetes Technol Ther; 2019 Feb; 21(2):73-80. PubMed ID: 30649925
[TBL] [Abstract][Full Text] [Related]
24. Closed-Loop Control of Postprandial Glycemia Using an Insulin-on-Board Limitation Through Continuous Action on Glucose Target.
Rossetti P; Quirós C; Moscardó V; Comas A; Giménez M; Ampudia-Blasco FJ; León F; Montaser E; Conget I; Bondia J; Vehí J
Diabetes Technol Ther; 2017 Jun; 19(6):355-362. PubMed ID: 28459603
[TBL] [Abstract][Full Text] [Related]
25. Multicenter outpatient dinner/overnight reduction of hypoglycemia and increased time of glucose in target with a wearable artificial pancreas using modular model predictive control in adults with type 1 diabetes.
Del Favero S; Place J; Kropff J; Messori M; Keith-Hynes P; Visentin R; Monaro M; Galasso S; Boscari F; Toffanin C; Di Palma F; Lanzola G; Scarpellini S; Farret A; Kovatchev B; Avogaro A; Bruttomesso D; Magni L; DeVries JH; Cobelli C; Renard E;
Diabetes Obes Metab; 2015 May; 17(5):468-76. PubMed ID: 25600304
[TBL] [Abstract][Full Text] [Related]
26. Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: the Virginia experience.
Clarke WL; Anderson S; Breton M; Patek S; Kashmer L; Kovatchev B
J Diabetes Sci Technol; 2009 Sep; 3(5):1031-8. PubMed ID: 20144416
[TBL] [Abstract][Full Text] [Related]
27. Safety, efficacy and glucose turnover of reduced prandial boluses during closed-loop therapy in adolescents with type 1 diabetes: a randomized clinical trial.
Elleri D; Biagioni M; Allen JM; Kumareswaran K; Leelarathna L; Caldwell K; Nodale M; Wilinska ME; Haidar A; Calhoun P; Kollman C; Jackson NC; Umpleby AM; Acerini CL; Dunger DB; Hovorka R
Diabetes Obes Metab; 2015 Dec; 17(12):1173-9. PubMed ID: 26257323
[TBL] [Abstract][Full Text] [Related]
28. Multicenter closed-loop/hybrid meal bolus insulin delivery with type 1 diabetes.
Chase HP; Doyle FJ; Zisser H; Renard E; Nimri R; Cobelli C; Buckingham BA; Maahs DM; Anderson S; Magni L; Lum J; Calhoun P; Kollman C; Beck RW;
Diabetes Technol Ther; 2014 Oct; 16(10):623-32. PubMed ID: 25188375
[TBL] [Abstract][Full Text] [Related]
29. A fully artificial pancreas versus a hybrid artificial pancreas for type 1 diabetes: a single-centre, open-label, randomised controlled, crossover, non-inferiority trial.
Tsoukas MA; Majdpour D; Yale JF; Fathi AE; Garfield N; Rutkowski J; Rene J; Legault L; Haidar A
Lancet Digit Health; 2021 Nov; 3(11):e723-e732. PubMed ID: 34580055
[TBL] [Abstract][Full Text] [Related]
30. The "Glucositter" overnight automated closed loop system for type 1 diabetes: a randomized crossover trial.
Nimri R; Danne T; Kordonouri O; Atlas E; Bratina N; Biester T; Avbelj M; Miller S; Muller I; Phillip M; Battelino T
Pediatr Diabetes; 2013 May; 14(3):159-67. PubMed ID: 23448393
[TBL] [Abstract][Full Text] [Related]
31. Advanced hybrid artificial pancreas system improves on unannounced meal response - In silico comparison to currently available system.
Garcia-Tirado J; Lv D; Corbett JP; Colmegna P; Breton MD
Comput Methods Programs Biomed; 2021 Nov; 211():106401. PubMed ID: 34560603
[TBL] [Abstract][Full Text] [Related]
32. Artificial Pancreas: Clinical Study in Latin America Without Premeal Insulin Boluses.
Sánchez-Peña R; Colmegna P; Garelli F; De Battista H; García-Violini D; Moscoso-Vásquez M; Rosales N; Fushimi E; Campos-Náñez E; Breton M; Beruto V; Scibona P; Rodriguez C; Giunta J; Simonovich V; Belloso WH; Cherñavvsky D; Grosembacher L
J Diabetes Sci Technol; 2018 Sep; 12(5):914-925. PubMed ID: 29998754
[TBL] [Abstract][Full Text] [Related]
33. Performance of an Automated Insulin Delivery System: Results of Early Phase Feasibility Studies.
Christiansen M; Bartee A; Lalonde A; Jones RE; Katz M; Wolpert H; Brazg R
Diabetes Technol Ther; 2021 Mar; 23(3):187-194. PubMed ID: 32940537
[No Abstract] [Full Text] [Related]
34. Randomized Crossover Comparison of Personalized MPC and PID Control Algorithms for the Artificial Pancreas.
Pinsker JE; Lee JB; Dassau E; Seborg DE; Bradley PK; Gondhalekar R; Bevier WC; Huyett L; Zisser HC; Doyle FJ
Diabetes Care; 2016 Jul; 39(7):1135-42. PubMed ID: 27289127
[TBL] [Abstract][Full Text] [Related]
35. Internal model control based module for the elimination of meal and exercise announcements in hybrid artificial pancreas systems.
Sala-Mira I; Garcia P; Díez JL; Bondia J
Comput Methods Programs Biomed; 2022 Nov; 226():107061. PubMed ID: 36116400
[TBL] [Abstract][Full Text] [Related]
36. Rate of Change of Premeal Glucose Measured by Continuous Glucose Monitoring Predicts Postmeal Glycemic Excursions in Patients With Type 1 Diabetes: Implications for Therapy.
Majithia AR; Wiltschko AB; Zheng H; Walford GA; Nathan DM
J Diabetes Sci Technol; 2018 Jan; 12(1):76-82. PubMed ID: 28868899
[TBL] [Abstract][Full Text] [Related]
37. Randomized Outpatient Trial of Single- and Dual-Hormone Closed-Loop Systems That Adapt to Exercise Using Wearable Sensors.
Castle JR; El Youssef J; Wilson LM; Reddy R; Resalat N; Branigan D; Ramsey K; Leitschuh J; Rajhbeharrysingh U; Senf B; Sugerman SM; Gabo V; Jacobs PG
Diabetes Care; 2018 Jul; 41(7):1471-1477. PubMed ID: 29752345
[TBL] [Abstract][Full Text] [Related]
38. Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas.
Weinzimer SA; Steil GM; Swan KL; Dziura J; Kurtz N; Tamborlane WV
Diabetes Care; 2008 May; 31(5):934-9. PubMed ID: 18252903
[TBL] [Abstract][Full Text] [Related]
39. Adjustment of Open-Loop Settings to Improve Closed-Loop Results in Type 1 Diabetes: A Multicenter Randomized Trial.
Dassau E; Brown SA; Basu A; Pinsker JE; Kudva YC; Gondhalekar R; Patek S; Lv D; Schiavon M; Lee JB; Dalla Man C; Hinshaw L; Castorino K; Mallad A; Dadlani V; McCrady-Spitzer SK; McElwee-Malloy M; Wakeman CA; Bevier WC; Bradley PK; Kovatchev B; Cobelli C; Zisser HC; Doyle FJ
J Clin Endocrinol Metab; 2015 Oct; 100(10):3878-86. PubMed ID: 26204135
[TBL] [Abstract][Full Text] [Related]
40. Glucose outcomes of a learning-type artificial pancreas with an unannounced meal in type 1 diabetes.
Song L; Liu C; Yang W; Zhang J; Kong X; Zhang B; Chen X; Wang N; Shen D; Li Z; Jin X; Shuai Y; Wang Y
Comput Methods Programs Biomed; 2020 Jul; 191():105416. PubMed ID: 32146213
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
